Multimodal Analgesia Effect on Post Surgical Patient

Phase 4 Active not recruiting 60 enrolled University of California, Davis

RandomizedParallel-groupOpen-labelTreatment

Summary

Patients undergoing Bariatric Surgery at the University of California Davis Medical Center will be divided into two groups, one receiving Standard of Care pain control medications vs the second group which will receive non-narcotic pain medications with rescue pain medications available if needed

Timeline

Start: 2021-01-20
Primary completion: 2026-06-24
Completion: 2026-06-24

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Acetaminophen	Small molecule	1000 mg	Oral
Subject	Gabapentin	Small molecule	100 mg	Intravenous
Background	Bupivacaine	Other / unclassified	0.25 %	Other
Background	Hydrocodone	Unknown	10 ml	—
Background	Hydrocodone	Unknown	15 ml	—
Background	Hydromorphone	Other / unclassified	0.5 mg	Intravenous
Background	Hydromorphone	Other / unclassified	1 mg	Intravenous
Background	Lorazepam	Small molecule	0.5 mg	Intravenous
Background	Ondansetron	Other / unclassified	4 mg	Intravenous
Background	Oxycodone	Other / unclassified	5 mg	Oral
Background	Oxycodone	Other / unclassified	10 mg	Oral
Background	Scopolamine	Unknown	—	Topical
Background	cyclobenzaprine	Small molecule	5 mg	Oral

Multimodal Analgesia Effect on Post Surgical Patient

Summary

Timeline

Drugs

Indications